Citigroup’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5
| Closed | – | – | 5094 |
|
|
2022
Q2 | $0 | Sell |
5
-20
| -80% | – | ﹤0.01% | 5482 |
|
|
2022
Q1 | $1K | Sell |
25
-76
| -75% | -$3.04K | ﹤0.01% | 5326 |
|
|
2021
Q4 | $5K | Buy |
101
+48
| +91% | +$2.38K | ﹤0.01% | 4875 |
|
|
2021
Q3 | $4K | Buy |
53
+28
| +112% | +$2.11K | ﹤0.01% | 4843 |
|
|
2021
Q2 | $21K | Sell |
25
-262
| -91% | -$220K | ﹤0.01% | 4592 |
|
|
2021
Q1 | $246K | Hold |
287
| – | – | ﹤0.01% | 3259 |
|
|
2020
Q4 | $261K | Buy |
287
+282
| +5,640% | +$256K | ﹤0.01% | 3072 |
|
|
2020
Q3 | $6K | Sell |
5
-2
| -29% | -$2.4K | ﹤0.01% | 4547 |
|
|
2020
Q2 | $2K | Sell |
7
-13
| -65% | -$3.71K | ﹤0.01% | 4934 |
|
|
2020
Q1 | $9K | Buy |
20
+4
| +25% | +$1.8K | ﹤0.01% | 4653 |
|
|
2019
Q4 | $3K | Sell |
16
-8
| -33% | -$1.5K | ﹤0.01% | 4950 |
|
|
2019
Q3 | $6K | Sell |
24
-13
| -35% | -$3.25K | ﹤0.01% | 4727 |
|
|
2019
Q2 | $92K | Sell |
37
-5
| -12% | -$12.4K | ﹤0.01% | 3692 |
|
|
2019
Q1 | $172K | Sell |
42
-1,177
| -97% | -$4.82M | ﹤0.01% | 3224 |
|
|
2018
Q4 | $3.75M | Buy |
1,219
+1,159
| +1,932% | +$3.57M | ﹤0.01% | 1170 |
|
|
2018
Q3 | $354K | Buy |
+60
| New | +$354K | ﹤0.01% | 2777 |
|
|
2018
Q2 | – | Sell |
-6
| Closed | -$28K | – | 4998 |
|
|
2018
Q1 | $28K | Sell |
6
-1
| -14% | -$4.67K | ﹤0.01% | 4059 |
|
|
2017
Q4 | $26K | Buy |
+7
| New | +$26K | ﹤0.01% | 4128 |
|
|
2017
Q3 | – | Hold |
0
| – | -$1K | – | 4736 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4689 |
|